1. Introduction {#sec1}
===============

Threatened abortion (TA), defined as vaginal bleeding with or without lower abdominal pain or backache with a closed cervix and an intrauterine viable fetus, is the commonest complication that occurs in early pregnancy \[[@B1]\], especially in 8-12 gestational weeks when the secretion of estrogen and progesterone shifts from corpus luteum to placental \[[@B2]\] (during the shift period, a pregnant woman is prone to go through limited corpus luteum function or an abnormality of placental progesterone production and secretion). TA affects one in five pregnancies, and about half of the cases unfortunately end in miscarriage \[[@B3], [@B4]\]. Besides, studies have shown that experiencing TA in the first trimester is associated with high risk of experiencing adverse pregnancy outcomes, such as premature rupture of membranes, placenta previa, and low birth weight \[[@B5]\]. TA is the cumulative result of several complicated pathogenic factors. Chromosomal abnormality is the important cause of TA that accounts for about 50-70% of cases \[[@B6], [@B7]\]. In addition, uterine malformations, cervical incompetence, polycystic ovaries, poorly controlled diabetes mellitus, maternal infections, immune dysfunctions such as antiphospholipid syndrome, and exposure to environmental toxins also have association with TA \[[@B7]--[@B9]\].

In clinical practice, targeted and directed treatment should be used to prevent miscarriage when specific causes are identified. For example, combined aspirin and heparin are effective in TA induced by antiphospholipid syndrome while antibiotics are useful for TA induced by bacterial vaginosis \[[@B7]\] and surgical interventions such as cervical cerclage are alternative and efficient for cervical incompetence. However, about half of the women suffering from miscarriage have no certain causes to be identified \[[@B10]\], making the treatment empirical. Generally, bed rest, avoidance of sexual intercourse, and drugs for some specific manifestations are usually prescribed for a woman with symptoms of TA \[[@B2], [@B11]\]. For instance, increased uterine activity is considered to be related to TA and so tocolytic drugs like magnesium sulfate and phloroglucinol (PHL) are commonly used for treatment \[[@B12]\]. Besides, since low serum human chorionic gonadotropin (hCG) and progesterone level increases the risk of miscarriage, drugs like exogenous progesterone \[[@B13], [@B14]\] and estrogen \[[@B15]\] are usually administrated to treat TA. What is more, anti-D immunoglobulin \[[@B16]\] is recommended for RhD-negative women with TA. In China, TA can be mainly attributed to the deficiency of the viscera especially the deficiency of the kidney according to the theories of traditional Chinese medicine (TCM). Herbs like Cuscutae Semen (Tusizi in Chinese), Herba Taxilli (Sangjisheng in Chinese), Dipsaci Radix (Xuduan in Chinese), and Astragali Radix (Huangqi in Chinese) are used to treat TA for their functions of replenishing the kidney essence (*Shen Jing* in Chinese) and nourishing the liver \[[@B17], [@B18]\]. Zeng et al. \[[@B19]\] and Li\'s \[[@B20]\] researches based on a data mining method have shown that Cuscutae Semen and Herba Taxilli were frequently prescribed for TA treatment and were always used in combination as an herb pair, indicating the key role of these two herbs in TA treatment and the representative value for other akin herbs to explore the potential mechanisms of action on TA treatment. Cuscutae Semen is the dry seed of Cuscuta australis and Cuscuta chinensis, which has been used for varieties of kidney conditions \[[@B21]\]. It has been reported to have neuroprotection properties in mouse models of Parkinson\'s disease \[[@B22]\] and anti-inflammatory properties \[[@B23], [@B24]\] and also be effective in treating vitiligo \[[@B25]\]. Herba Taxilli is the dry leafy stem and branch of Taxillus sutchuenensis (Lecomte) Danser which grows on various trees and shrubs \[[@B26]\] and has the anti-HCV \[[@B27]\] and antioxidant activities \[[@B28]\]. Generally speaking, herbal medicines own the features of multicomponents and multieffectiveness in treating diseases which makes it hard to clearly clarify the efficiency in a molecular level. Although Tusizi-Sangjisheng is widely used for the treatment of TA, the exact mechanisms of it remain to be further elucidated.

The objective of this study is to systematically explore the functional mechanism of the herb pair Tusizi-Sangjisheng in the molecular level and also to understand the relationship among those small chemicals, their related targets, and diseases. The results of this study may facilitate clarifying the mechanism of the Chinese herb pair Tusizi-Sangjisheng and offer some valuable methods for studying other akin herbs.

2. Materials and Methods {#sec2}
========================

2.1. Molecular Database and ADME Screening {#sec2.1}
------------------------------------------

All compounds of Tusizi-Sangjisheng in this study were collected by using the TCMSP database (<http://lsp.nwsuaf.edu.cn/tcmsp.php>) which comprises more than 510 herbal entries registered in Chinese pharmacopoeia with more than 33,000 ingredients. The rational assessment of absorption, distribution, metabolism, and excretion properties (ADME) of compounds is essential to decide drug candidates. In the present study, two ADME-related models, PreOB (predict oral bioavailability) and PreDL (predict drug likeness) of the drugs, were employed to prescreen the bioactive compounds. Oral bioavailability (%*F*) is considered a key parameter in drug development. Oral drug absorption is mainly about two basic parameters: solubility and gastrointestinal permeability of the drug. In detail, the PreOB model, developed on the basis of a robust in-house system OBioavail 1.1 \[[@B29]\], was performed to predict the OB of the constituents of the herbs. The molecules with suitable OB ≥ 30% were chosen as candidate compounds for further research. Drug likeness is a concept that is aimed at identifying where virtual or real molecules fall into drug-like chemical space based on one or more physiochemical properties. According to the mean value (0.18) of DL for all 3,206 molecules in DrugBank (<http://www.drugbank.ca/>), compounds with DL ≥ 0.18 were selected as the candidate bioactive chemicals in this study. Finally, a total of 75 compounds from Tusizi-Sangjisheng were obtained and 12 bioactive compounds among them were screened.

2.2. Target Identification and Network Construction {#sec2.2}
---------------------------------------------------

Target identification for bioactive compounds is an essential step for drug discovery. Predicting drug-target and drug-pathway interactions could help understand the biological mechanisms from the perspective of network pharmacology. To obtain the related targets of these active compounds, a SysDT \[[@B30]\] model based on Random forest (RF) and Support Vector Machine (SVM) was employed. The UniProt database (<https://www.uniprot.org/>) was used to search the genes of the human species and the corresponding UniProtKB related to the predicted targets of the bioactive molecules. Information on the physiological functions of all targets was obtained from TTD (<http://bidd.nus.edu.sg/group/ttd/>) and UniProt (<http://www.uniprot.org/>) databases. Additionally, to systematically study the effects of herbal medicines and to characterize the therapeutic effects on a pathway level, three visualized networks including Compound-Target (C-T), Target-Disease (T-D), and Target-Pathway (T-P) were constructed. And the obtained target profiles were organized into several pathways by mapping to KEGG (Kyoto Encyclopedia of Genes and Genomes). All bipartite graphs were drawn by Cytoscape 3.5.1 software \[[@B31]\].

3. Results {#sec3}
==========

3.1. Potential Active Compounds {#sec3.1}
-------------------------------

In this study, a total of 75 compounds of the Tusizi-Sangjisheng (29 for Tusizi and 46 for Sangjisheng) were included. After screening all compounds at the criteria that OB ≥ 30% and DL ≥ 0.18, 12 bioactive compounds with excellent ADME properties were obtained and the specific information is shown in [Table 1](#tab1){ref-type="table"}.

3.2. Drug Targeting and Network Analysis {#sec3.2}
----------------------------------------

Traditionally, herbal medicines contain numerous pharmacological compounds, which offer bright prospects for the treatment of complex diseases in a synergistic manner. Network pharmacology has undergone a rapid development in recent years and emerged as an invaluable tool for describing and analyzing complex systems in pharmacology studies. Considering that the multicomponent herbs exert effects on diseases by acting to specific protein targets, drug targeting may shed light on the mechanism of herbs treating TA from the perspective of network pharmacology. In this study, after target fishing by the SysDT \[[@B30]\] model, a total of 153 targets were screened which were targeted by 10 bioactive compounds (two of the 12 bioactive compounds had no direct targets) from Tusizi-Sangjisheng. The detailed information is presented in [Table 2](#tab2){ref-type="table"}.

### 3.2.1. Compound-Target Network {#sec3.2.1}

In order to uncover the synergistic effects of multiple components and targets in Tusizi-Sangjisheng, a C-T network analysis was carried out. After excluding 2 bioactive compounds which have no directly related targets, a graph of C-T interactions was drawn ([Figure 1](#fig1){ref-type="fig"}) using 10 bioactive compounds and 153 related targets. As shown in [Figure 1](#fig1){ref-type="fig"}, the blue squares represent bioactive molecules in Tusizi-Sangjisheng, and pink circles represent the corresponding targets. Among the 10 compounds, quercetin owns the highest degree (degree = 108), followed by kaempferol, beta-sitosterol, and isorhamnetin, indicating the key roles of these chemicals in Tusizi-Sangjisheng. Targets like prostaglandin G/H synthase 1 (PTGS1), nitric oxide synthase (NOS), tumor necrosis factor (TNF), interleukins-6 (IL-6), and caspase have a high degree of connectivity, revealing the potential functions of treating TA.

### 3.2.2. Target-Disease Network {#sec3.2.2}

Disease-related genes interact in their products and expression patterns. Disease and disease genes are linked together to form a network through known correlations. A variety of disease network diagrams can be generated from the interdependence of cell networks based on human diseases. In these figures, if the phenotype of a disease is related to a molecule, different phenotypes will be linked \[[@B32]\]. In addition, disorders of human diseases should be viewed as disorders of highly connected networks within cells. These new advances and understandings provide a platform for studying the relationship between known genes and diseases, which means that different diseases may originate from the same gene \[[@B33]\].

Existing data and theories make it possible to use network methods to study diseases from different scales. Complex network systems can visually reveal the complex relationships among diseases, genes, and pathways to a certain extent. Since the application of network models to biology, many researchers have constructed networks of different functions and properties. These network models have shown us their value in biological researches. At present, the research on diseases mainly includes protein-protein relationship networks, metabolic networks, and regulatory networks. We established a Target-Disease network to study protein-protein interactions and to understand the complex mechanism of action of TCM. This network showed that different diseases have common pathological changes and can be cured by the same compound; that is, one compound can correspond to multiple diseases.

The OMIM database (<http://www.omim.org/>) was used to search target genes related to TA, and the search term was "threatened miscarriage" or "threatened abortion". The target genes corresponding to the disease is compared with those corresponding to the bioactive compounds, and the common ones are the target genes of the drug in treating TA. A total of 455 targets related to TA were collected through the OMIM database. Comparing it with the 153 targets corresponding to the bioactive compounds of Tusizi-Sangjisheng, 31 common targets preventing miscarriage were obtained. As shown in [Figure 2](#fig2){ref-type="fig"}, the outer blue circles represent the targets of Tusizi-Sangjisheng and the inner pink circles represent the targets of TA.

### 3.2.3. Target-Pathway Network {#sec3.2.3}

As concerns the effects of drugs that are related to target proteins and also signaling pathways associated with diseases, Target-Pathway network was drawn to analyze the action mechanism of Tusizi-Sangjisheng. As shown in [Figure 3](#fig3){ref-type="fig"}, the network consists of 116 nodes and 381 edges, and all proteins are involved in more than one signal pathway correlation, forming a highly interconnected network.

3.3. GO Analysis {#sec3.3}
----------------

Upload the predicted target genes to the DAVID database (Version 6.8, <https://david.ncifcrf.gov/>) and perform GO enrichment analysis. We found that these targets are closely related to various biological processes, such as the RNA polymerase II promoter positive regulation of transcription, positive regulation of reactive oxygen metabolic processes, and inflammatory responses to multicellular biological processes.

3.4. Pathway Analysis {#sec3.4}
---------------------

The top three pathways with the highest degrees in [Figure 4](#fig4){ref-type="fig"} are mitogen-activated protein kinase (MAPK) signaling pathway, the phosphatidylinositol-3-kinase/protein kinase B (PI3K-Akt) signaling pathway, and the transforming growth factor-*β* (TGF-*β*) signal transduction pathway. As shown in [Figure 5](#fig5){ref-type="fig"}, the MAPK signal pathway is related to targets TNF, IL1, CACN, CASP, JNK, and MAPK14 and exerts the functions of proliferation, differentiation, and inflammation. Up to six targets are involved in the PI3K-Akt pathway as important regulators for the cell progression and survival, including CHRM1, CHRM2, p27, CHUK, Myc, and CDK2. And the TGF-*β* signal pathway acts on TGFB1 and Myc targets.

4. Discussions {#sec4}
==============

4.1. Bioactive Compounds of the Tusizi-Sangjisheng Herb Pair {#sec4.1}
------------------------------------------------------------

In this study, we used systematic pharmacology to study Tusizi-Sangjisheng and found that this herb pair has a total of 12 compounds with good OB and DL properties, which are related to 153 target proteins. The most potent compounds in Tusizi-Sangjisheng is quercetin which is followed by kaempferol, *β*-sitosterol, and isorhamnetin. Quercetin, kaempferol, and isorhamnetin are all flavonoids that are abundant in amount and widely distributed in nature. Quercetin is one of the phytochemicals with anticancer and antioxidant activities that widely exists in nuts, teas, vegetables, herbs, and generally diet of people \[[@B34], [@B35]\]. In addition to the above effects, quercetin still has the anti-inflammatory functions by blocking the secretion of IL-6, IFN-*γ*, and TNF-*α* and increasing the decreased ratio of Bcl-2/Bax apoptotic proteins induced by lipopolysaccharide (LPS) revealing the putative value in preventing miscarriage caused by bacterial infection \[[@B36]--[@B38]\]. Kaempferol is a typical natural flavonol and has been reported to own many beneficial functions such as anti-inflammatory, antioxidative, antiatherogenic, hepatoprotective, neuroprotective, antidiabetic, and anticancer activities \[[@B39], [@B40]\]. It is well known for its prominent antioxidative activity \[[@B39]\], and the main mechanisms include decreasing the susceptibility of low-density lipoproteins (LDL) to oxidation, inhibiting the release of cytochrome C, scavenging excessive reactive oxygen species (ROS), and inhibiting the generation of ROS by regulating the level of NOS/NO, reducing the accumulation of toxic lipid peroxidation product malondialdehyde (MDA), and maintaining the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) in a normal level \[[@B41]--[@B43]\]. Isorhamnetin is a flavonoid present in many plants and has been reported to protect against inflammatory and oxidative stress responses in various in vitro and in vivo models using LPS, inflammatory cytokines, and ischemic injury. The anti-inflammatory function of isorhamnetin is regarded to be related to inhibition of NF-*κ*B signaling activity, and its antioxidative effect is associated with ROS blocking \[[@B44]\]. Besides, isorhamnetin also has the anticancer activity by acting on Akt and MAPK signal pathways \[[@B45]\]. *β*-Sitosterol, one of the several phytosterols, is a natural micronutrient in higher plants possessing numerous physiological effects including antioxidative, anticancer, anti-inflammatory, antidiabetic, and immune modulation activities \[[@B46]\]. Although quercetin, kaempferol, isorhamnetin, and *β*-sitosterol have wide pharmacological functions, the detailed correlation with TA is still unclear and needs to be further studied.

4.2. Main Targets of the Tusizi-Sangjisheng Herb Pair {#sec4.2}
-----------------------------------------------------

### 4.2.1. PTGS {#sec4.2.1}

PTGS, also known as cyclooxygenase (COX) \[[@B47]\], is a crucial enzyme for the synthesis of prostaglandins (PG) in the body, which can transform arachidonic acid into various types of PGs. There are three known subtypes of PTGS: PTGS1, PTGS2, and PTGS3. PTGS1 exists in most cells and exerts the function of maintaining and regulating the normal physiological activities by synthesizing PG. PG is closely related to physiological processes such as endometrial vascular regeneration, vascular permeability, and establishment of a placental vascular network during pregnancy \[[@B48]\]. COX is considered a key factor in implantation \[[@B49]\]. Studies have shown that the expression level of COX-2 in the women\'s endometrium during the midluteal phase of women\'s menstrual cycles begins to create the necessary conditions for conception. Once trophoblast invasion occurs, the COX-2 content at the invaded site will increase continuously \[[@B50]\], and IL-1 was found to increase COX-2 expression in endometrial cells at the implantation site \[[@B51]\]. The expression of COX in patients with TA/recurrent miscarriage is lower than that in normal pregnancy, which may interfere the process of embryo implantation through various PG molecules it catalyzes and participate in the pathogenic process of TA.

### 4.2.2. NOS {#sec4.2.2}

NOS is the only rate-limiting enzyme that synthesizes NO. It belongs to isozymes and has three subtypes: neuronal (nNOS/NOS1), inducible (iNOS/NOS2), and endothelial NOS (eNOS/NOS3) \[[@B52]\], among which NOS3 is mainly expressed in vascular endothelial cells and catalyzes the production of intravascular NO. NO is a signaling molecule in the cardiovascular system that has the properties of smooth muscle relaxation, platelet inhibition, leukocyte aggregation, and also attenuation of vascular smooth muscle cell proliferation, neurotransmission, and immune defense \[[@B53]\]. NOS3 is also expressed in the placental tissue during pregnancy. It promotes the synthesis of NO to participate in the regulation of blood circulation in the placenta, causing a slight decrease in vascular resistance and blood pressure, which is of great significance for maintaining uterine placental blood flow. Studies have found that the expression of NOS in endothelial cells in the plasma and placenta is increased in women with preeclampsia of its compensatory mechanisms \[[@B54], [@B55]\]. The hypothesis of the pathogenesis of preeclampsia is that the expression of NOS decreased and NO synthesis reduced, resulting in increased vascular bed resistance and blocked placental blood circulation, while the successful pregnancy during the first trimester depends on the favoring invasion of trophoblasts to the endometrium and the success remodeling of the uterine spiral arteries, and NO plays important roles in this process. Paradisi et al.\'s research has shown that serum NO levels in patients with TA are lower than those in normal pregnancy \[[@B56]\], indicating that TA may be associated with decreased NOS expression which is similar to that of preeclampsia. A reduced NO level results in the disturbance of maternal-fetal circulation and further influences the supply of blood and oxygen which may cause TA.

### 4.2.3. TNF {#sec4.2.3}

TNF is a cytokine secreted by macrophages that can directly cause death of tumor cells. TNF-*α* and TNF-*β* are the two known types of TNF that can be expressed in immune cells such as T and B cells. IL-6 (interleukin 6), which belongs to the Th2-type cytokine, is a type of cytokine involved in a variety of immune inflammatory responses that could inhibit Th1-mediated immune responses. Th1 immunity causes loss of pregnancy while Th2 immunity helps to maintain pregnancy, so the ratio of Th1/Th2 is crucial for pregnancy. If the balance of Th1/Th2 is broken, TA or miscarriage may occur. TNF-*α* is mainly expressed by Th1 and NK cells that can kill tumor cells and also attack trophoblast cells and embryonic tissues. A high serum level of TNF-*α* and inadequate expression of IL-6 in endometrial tissue have been found in patients with recurrent abortion, revealing that the overproduction of TNF or underactivation of IL-6 may cause fetus damage and loss \[[@B57], [@B58]\]. In this study, the active ingredients in Tusizi-Sangjisheng act on the targets IL-6 and TNF-*α* to promote the expression of IL-6, increase its level in plasma and decidual tissue, and then inhibit the expression of TNF-*α* so as to reduce the maternal immune response against the fetus and maintain the normal development of the pregnancy.

### 4.2.4. Caspase {#sec4.2.4}

Caspase is a type of protease and an important mediator of programmed cell death (apoptosis) that includes caspase-1 (containing caspase-1, 4, 5, and 11), caspase-2 (containing caspase-2 and 9), and caspase-3 (containing caspase-3, 6, 7, 8, and 10). Among them, caspase-3 is mainly expressed in the cytoplasm of trophoblast cells and could regulate cell growth and apoptosis by activating the Fas pathway. Apoptosis is essential for the normal physiology of pregnancy during implantation since apoptosis of trophoblast cells is important for the appropriate tissue remodeling of the maternal decidua and invasion of the developing embryo \[[@B59], [@B60]\]. The overexpression of caspase-3 will cause abnormal apoptosis of trophoblasts, affect embryo development, and result in abortion. Meresman et al.\'s study indicated that the expression level of caspase-3 in out-of-phase endometrium abortion patients is higher than that in normal, and the decreased cell proliferation and augmented cell apoptosis were also found \[[@B61]\]. The bioactive components of Tusizi-Sangjisheng may act on caspase-3 and suppress its expression to reduce the apoptosis of trophoblast cells.

4.3. Signal Pathways of the Tusizi-Sangjisheng Herb Pair {#sec4.3}
--------------------------------------------------------

### 4.3.1. MAPK Signal Pathway {#sec4.3.1}

MAPK is a class of serine/threonine protein kinases and widely present in various cells. It has important regulatory effects on gene expression. After activation, the protein migrates into the phosphorylated nucleoproteins and membrane receptors, regulating gene transcription and other life events. It consists of four separate signaling cascades: the JNK/SAPK (c-Jun N-terminal kinase/stress-activated protein kinases); the ERKs (extracellular signal-regulated kinases); the ERK5 or big MAPK1; and the p38MAPK group of protein kinases. When stimulated by extracellular signals, the MAPK cascade which is an evolutionarily conserved tertiary kinase cascade transduction signal will be activated by a series of complicated chemical reactions, resulting in the successive activation of MAPKKK, MAPKK, and MAPK through the phosphorylation of amino acid residues \[[@B62]\]. Evidences have shown that the MAPK signal pathway is activated in many processes during embryo implantation and is closely related to the invasion and proliferation of trophoblast cells and decidual stromal cells (DSCs) which play key roles in the maintenance of normal pregnancy \[[@B63], [@B64]\]. Z. Wang et al.\'s research demonstrated the abnormal expressions of nucleotide-binding oligomerization domains 1 and 2 (NOD 1 and NOD 2) in villi from recurrent spontaneous abortion (RSA) patients that then inhibit the invasion and proliferation of trophoblast cells by activating the p38MAPK signal pathway \[[@B65]\]. In addition, inflammation (including sterile inflammation or infectious inflammation induced by bacteria such as bacterial vaginosis) and oxidative stress (smoking) could also activate the p38MAPK signal pathway and thus attenuate the normal development of trophoblast cells \[[@B66]\]. Furthermore, the activation of the JNK and ERK1/2 signal pathway by interleukin (IL)-33 \[[@B67]\] and IL-25 \[[@B68]\] also leads to the enhancement of invasion and proliferation of DSCs. Accordingly, for the similar pathogenesis between RAS and TA, the role of the MAPK signal pathway could also be considered by affecting the invasion and proliferation of trophoblast cells and DSCs even though there is no direct evidence. The total flavones of Cuscutae Semen were found to be effective in suppressing abortion by inhibiting MAPK pathways \[[@B69]\], indicating the potential mechanism of the herb pair Tusizi-Sangjisheng treating TA.

### 4.3.2. PI3K-Akt Signal Pathway {#sec4.3.2}

The PI3K-Akt signal pathway consists of phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB, also known as Akt) and is involved in transcription, protein synthesis, migration, apoptosis, and proliferation activities \[[@B70]\]. Identically, the PI3K-Akt signaling pathway also participates in the proliferation and migration of trophoblast cells that are vital for establishing and persisting normal success pregnancy. Evidence has shown that the up-/downregulation of the PI3K-Akt signal pathway is related to the proliferation and migration of trophoblast cells \[[@B71]\]. PI3K signaling is considered to have association with the secretion of several hormones including gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) that are important in the maintenance of normal pregnancy \[[@B72]\]. In addition, PI3K could also regulate insulin signaling via activating the Akt pathway \[[@B72]\]. Generally, obese persons with insulin resistance are often companied by reduced hypothalamic GnRH secretion and decreased fertility \[[@B73]\]. An experimental study also demonstrated that herbal decoctions containing herbs prevent miscarriage and are effective to promote the follicle development and fertility via activation of the PI3K-Akt signal pathway \[[@B74]\]. Accordingly, we assume that Tusizi-Sangjisheng may suppress miscarriage via the PI3K-Akt signal pathway by influencing the expression of sex hormones GnRH/LH and also the proliferation and migration of trophoblast cells.

### 4.3.3. TGF-*β* Signal Pathway {#sec4.3.3}

TGF-*β* is a multifunctional cytokine with three isoforms (TGF-*β*1, TGF-*β*2, and TGF-*β*3) and acts mainly through Smad pathways \[[@B75]\]. Evidences have proved that TGF-*β* plays pivotal and dual roles in the regulation of cell growth and apoptosis which is vividly described as a "switch" \[[@B76]\]. During early pregnancy, the uterine cells undergo apoptosis and proliferation for the successful implantation of embryo. Those complex processes are controlled and regulated by several signal pathways, and the TGF-*β* signal pathway is one of them that could help to maintain normal pregnancy by balancing the proliferation and apoptosis of trophoblast cells \[[@B75]\]. In addition, the TGF-*β* signal pathway is also involved in immune and inflammatory responses by regulating indoleamine 2,3-dioxygense (IDO) expression to promote immune tolerance of the maternal-fetal interface \[[@B77]\], inhibiting the proliferation of human Th1 memory T cells \[[@B78]\]. At present, there is no direct evidence illustrating the specific relationship among herbs like Cuscutae Semen and the TGF-*β* signal pathway in TA. Yet we can hypothesize based on the above information that the active ingredients in the herb pair Tusizi-Sangjisheng exert their TA-preventing function by regulating the immune responses in maternal-fetal interface and controlling the normal apoptosis and proliferation of uterine cells through the TGF-*β* signal pathway.

In normal pregnancy, the balance of the immune microenvironment at the maternal-fetal interface can ensure immune tolerance and protect the embryo from maternal immune rejection. The ability of gestational trophoblasts to proliferate, differentiate, migrate, and invade is crucial for embryo implantation, placenta formation, and embryo growth and development. Trophoblasts are the main cell types of placental tissues that differentiate into extravillous trophoblasts, syncytiotrophoblasts and cell trophoblasts. Extravillous trophoblasts can be further differentiated into cells with high infiltration capacity. Interstitial trophoblast cells and intravascular trophoblast cells then invade the uterine decidua and reshape the spiral arteries of a pregnant uterus, thereby forming placental tissues which provide nutrients for the development of the embryo. Therefore, infiltration of trophoblasts into the uterine decidua is the key step to the success of early pregnancy. If the ability of trophoblasts to proliferate, migrate, and invade is weakened, it will affect the remodeling of decidual tissue blood vessels and the formation of placenta and further develop into pregnancy-dependent complications such as abortion, preeclampsia, and intrauterine growth restriction. These processes during pregnancy are jointly regulated by many signal transduction pathways. However, the exact regulatory mechanisms are still not very clear. Three key signaling pathways mentioned above were screened by systematic methods in this study revealing that Tusizi-Sangjisheng may effectively reduce miscarriage rates via regulating the normal expression and function of those three signal pathways, correcting under- or overexpression and maintaining normal pregnancy.

5. Conclusions {#sec5}
==============

The putative mechanisms in the molecular level of the commonly used herb pair Tusizi-Sangjisheng treating TA were analyzed by systems pharmacology. 12 bioactive molecules with OB ≥ 30% and DL ≥ 0.18 of Tusizi-Sangjisheng were obtained by calculating the ADME properties. Besides, a total of 153 direct targets of 12 bioactive molecules were predicted by systematic models. By constructing a T-D network for analysis, 31 targets mainly containing PTGS1, NOS3, TNF, and caspase were found to be directly related to TA among the corresponding targets of Tusizi-Sangjisheng and TA was considered a complex disease with multifaceted causes that need to be treated from multiple angles by GO analysis. Through the T-P network enrichment analysis, Tusizi-Sangjisheng was found to act on multiple pathways by several active molecules that include MAPK, PI3K-Akt, and TGF-*β* signaling pathways. The mechanism of Tusizi-Sangjisheng on the treatment of TA may be through regulating the normal expression of the above three signal pathways, correcting the state of under- or overexpression, and maintaining normal pregnancy.
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![Compound-Target network (C-T). The blue squares represent 153 targets related to active compounds, and the pink circles represent the 10 bioactive compounds.](BMRI2020-4748264.001){#fig1}

![Target-Disease network (T-D). The outer blue circles represent targets related to Tusizi-Sangjisheng, and the inner pink circles represent the targets of TA.](BMRI2020-4748264.002){#fig2}

![Target-Pathway network (T-P).](BMRI2020-4748264.003){#fig3}

![Gene Ontology (GO) analysis of target genes for treatment. The *y*-axis shows a significantly rich "biological process" category in the GO of the target gene, and the *x*-axis shows the enrichment score of these terms.](BMRI2020-4748264.004){#fig4}

![Distribution of the target proteins on compressed TA pathways.](BMRI2020-4748264.005){#fig5}

###### 

Bioactive compounds of Cuscutae Semen and Herba Taxilli.

  ID          Compound                OB      DL     Herb name
  ----------- ----------------------- ------- ------ ------------------------------
  MOL001558   Sesamin                 56.55   0.83   Cuscutae Semen
  MOL000184   NSC63551                39.25   0.76   Cuscutae Semen
  MOL000098   Quercetin               46.43   0.28   Herba Taxilli/Cuscutae Semen
  MOL000354   Isorhamnetin            49.60   0.31   Cuscutae Semen
  MOL000358   Beta-sitosterol         36.91   0.75   Cuscutae Semen
  MOL000422   Kaempferol              41.88   0.24   Cuscutae Semen
  MOL000953   CLR                     37.87   0.68   Cuscutae Semen
  MOL005043   Campest-5-en-3beta-ol   37.58   0.71   Cuscutae Semen
  MOL005440   Isofucosterol           43.78   0.76   Cuscutae Semen
  MOL005944   Matrine                 63.77   0.25   Cuscutae Semen
  MOL006649   Sophranol               55.42   0.28   Cuscutae Semen
  MOL000359   Sitosterol              36.91   0.75   Herba Taxilli

###### 

The information of related targets of the Tusizi-Sangjisheng herb pair.

  No.   Target name                                                                       Gene name   UniProt ID
  ----- --------------------------------------------------------------------------------- ----------- ------------
  1     26S proteasome non-ATPase regulatory subunit 3                                    PSMD10      O75832
  2     72 kDa type IV collagenase                                                        MMP2        P08253
  3     78 kDa glucose-regulated protein                                                  HSPA5       P11021
  4     Acetylcholinesterase                                                              ACHE        P22303
  5     Activator of 90 kDa heat shock protein ATPase homolog 1                           AHSA1       O95433
  6     Androgen receptor                                                                 NCOA4       Q13772
  7     Apoptosis regulator BAX                                                           BAX         Q07812
  8     Arachidonate 5-lipoxygenase                                                       ALOX5       P09917
  9     ATP-binding cassette subfamily G member 2                                         ABCG5       Q9H222
  10    Baculoviral IAP repeat-containing protein 5                                       BIRC5       O15392
  11    Bcl-2-like protein 1                                                              BCL2L1      Q07817
  12    Beta-2 adrenergic receptor                                                        ADRB2       P07550
  13    Caspase-8                                                                         CASP8       Q14790
  14    Cathepsin D                                                                       CTSD        P07339
  15    Caveolin-1                                                                        CAV1        Q03135
  16    CD40 ligand                                                                       CD40LG      P29965
  17    Cellular tumor antigen p53                                                        TP53        P04637
  18    Claudin-4                                                                         CLDN4       O14493
  19    Coagulation factor VII                                                            F7          P08709
  20    C-reactive protein                                                                CRP         P02741
  21    C-X-C motif chemokine 10                                                          CXCL10      P02778
  22    C-X-C motif chemokine 11                                                          CXCL11      O14625
  23    C-X-C motif chemokine 2                                                           CXCL2       P19875
  24    Cyclin-dependent kinase inhibitor 1                                               CDKN1B      P46527
  25    Cytochrome P450 1A1                                                               CYP1A1      P04798
  26    Cytochrome P450 1B1                                                               CYP1B1      Q16678
  27    Cytochrome P450 3A4                                                               CYP3A4      P08684
  28    DDB1- and CUL4-associated factor 5                                                DCAF5       Q96JK2
  29    Dipeptidyl peptidase IV                                                           DPP4        P27487
  30    DNA topoisomerase 1                                                               TOP1        P11387
  31    E-selectin                                                                        SELE        P16581
  32    Estrogen sulfotransferase                                                         SULT1E1     P49888
  33    ETS domain-containing protein Elk-1                                               ELK1        P19419
  34    G1/S-specific cyclin-D1                                                           CCND1       P24385
  35    G2/mitotic-specific cyclin-B1                                                     CCNB1       P14635
  36    Gamma-aminobutyric acid receptor subunit alpha-1                                  GABRA1      P14867
  37    Glutathione S-transferase Mu 1                                                    GSTM1       P09488
  38    Heat shock factor protein 1                                                       HSF1        Q00613
  39    Heme oxygenase 1                                                                  HMOX1       P09601
  40    Inhibitor of nuclear factor kappa-B kinase subunit alpha                          CHUK        O15111
  41    Insulin receptor                                                                  INSR        P06213
  42    Interleukin-1 alpha                                                               IL1A        P01583
  43    Interleukin-1 beta                                                                IL1B        P01584
  44    Interleukin-10                                                                    IL10        P22301
  45    Interleukin-2                                                                     IL2         P60568
  46    Interleukin-6                                                                     IL6         P05231
  47    Interleukin-8                                                                     CXCL8       P10145
  48    Interstitial collagenase                                                          MMP1        P03956
  49    Mitogen-activated protein kinase 1                                                Mapk1       P63085
  50    mRNA of PKA catalytic subunit C-alpha                                             PRKACA      P17612
  51    Myc protooncogene protein                                                         MYC         P01106
  52    Myeloperoxidase                                                                   MPO         P05164
  53    Neutrophil cytosol factor 1                                                       NCF1        P14598
  54    Nuclear factor erythroid 2-related factor 2                                       NFE2L2      Q16236
  55    Nuclear receptor coactivator 2                                                    NCOA2       Q15596
  56    Peroxisome proliferator-activated receptor alpha                                  PPARA       Q07869
  57    Peroxisome proliferator activated receptor delta                                  PPARD       Q03181
  58    Peroxisome proliferator activated receptor gamma                                  PPARG       P37231
  59    Plasminogen activator inhibitor 1                                                 SERPINE1    P05121
  60    Poly \[ADP-ribose\] polymerase 1                                                  TNKS        O95271
  61    Potassium voltage-gated channel subfamily H member 2                              KCNH2       Q12809
  62    Prostaglandin G/H synthase 1                                                      PTGS1       P23219
  63    Protooncogene c-Fos                                                               FOS         P01100
  64    Puromycin-sensitive aminopeptidase                                                NPEPPS      P55786
  65    RAC-alpha serine/threonine-protein kinase                                         AKT1        P31749
  66    RAF protooncogene serine/threonine-protein kinase                                 RAF1        P04049
  67    Ras association domain-containing protein 1                                       RASSF1      Q9NS23
  68    Ras GTPase-activating protein 1                                                   RASA1       P20936
  69    Receptor tyrosine-protein kinase erbB-2                                           ERBB2       P04626
  70    Receptor tyrosine-protein kinase erbB-3                                           ERBB3       P21860
  71    Retinoic acid receptor RXR-alpha                                                  RXRA        P19793
  72    Runt-related transcription factor 2                                               RUNX2       Q13950
  73    Serine/threonine-protein kinase Chk2                                              CHEK2       O96017
  74    Serum paraoxonase/arylesterase 1                                                  PON1        P27169
  75    Sodium channel protein type 5 subunit alpha                                       SCN5A       Q14524
  76    Solute carrier family 2, facilitated glucose transporter member 4                 SLC2A4      P14672
  77    Stromelysin-1                                                                     MMP3        P08254
  78    Thrombin                                                                          F2          P00734
  79    Thrombomodulin                                                                    THBD        P07204
  80    Transcription factor AP-1                                                         JUN         P05412
  81    Transcription factor E2F1                                                         E2F1        Q01094
  82    Transcription factor E2F2                                                         E2F2        Q14209
  83    Transcription factor p65                                                          RELA        Q04206
  84    Trypsin-1                                                                         PRSS1       P07477
  85    Type I iodothyronine deiodinase                                                   DIO1        P49895
  86    Xanthine dehydrogenase/oxidase                                                    XDH         P47989
  87    2,4-Dienoyl-CoA reductase, mitochondrial                                          DECR1       Q16698
  88    Acetyl-CoA carboxylase 1                                                          ACACA       Q13085
  89    ATP-citrate synthase                                                              ACLY        P53396
  90    Coagulation factor Xa                                                             F10         P00742
  91    Cytochrome P450 2B6                                                               CYP2B6      P20813
  92    Endothelin-converting enzyme 1                                                    ECE1        P42892
  93    Glucose-6-phosphate 1-dehydrogenase                                               G6PD        P11413
  94    NADPH oxidase 1                                                                   NOX1        Q9Y5S8
  95    NADPH oxidase 3                                                                   NOX3        Q9HBY0
  96    Nitric oxide synthase, endothelial                                                NOS3        P29474
  97    Peroxisomal acyl-coenzyme A oxidase 1                                             ACOX1       Q15067
  98    Peroxisomal bifunctional enzyme                                                   EHHADH      Q08426
  99    Sterol regulatory element-binding protein 1                                       SREBF1      P36956
  100   Aldose reductase                                                                  AKR1B10     O60218
  101   Amine oxidase \[flavin-containing\] B                                             MAOB        P27338
  102   Cyclin-A2                                                                         CCNA2       P20248
  103   Estrogen receptor beta                                                            ESRRB       O95718
  104   Glutamate receptor 2                                                              GRIA2       P42262
  105   Mitogen-activated protein kinase 14                                               MAPK14      Q16539
  106   Nitric oxide synthase, inducible                                                  NOS2        P35228
  107   Nuclear receptor coactivator 1                                                    NCOA1       Q15788
  108   Protooncogene serine/threonine-protein kinase Pim-1                               PIM1        P11309
  109   Serine/threonine-protein kinase Chk1                                              CHEK1       O14757
  110   5-Hydroxytryptamine 2A receptor                                                   HTR2A       P28223
  111   Alpha-1A adrenergic receptor                                                      ADRA1A      P35348
  112   Alpha-1B adrenergic receptor                                                      ADRA1B      P35368
  113   Caspase-9                                                                         CASP9       P55211
  114   Dopamine D1 receptor                                                              DRD1        Q95136
  115   Gamma-aminobutyric-acid receptor alpha-3 subunit                                  GABRA3      P34903
  116   Gamma-aminobutyric-acid receptor alpha-5 subunit                                  GABRA5      P31644
  117   Muscarinic acetylcholine receptor M2                                              CHRM2       P08172
  118   Muscarinic acetylcholine receptor M3                                              CHRM3       P20309
  119   Muscarinic acetylcholine receptor M4                                              CHRM4       P08173
  120   Mu-type opioid receptor                                                           OPRM1       P35372
  121   Neuronal acetylcholine receptor protein, alpha-7 chain                            CHRNA7      P36544
  122   Neuronal acetylcholine receptor subunit alpha-2                                   CHRNA2      Q15822
  123   Sodium-dependent serotonin transporter                                            SLC6A4      P31645
  124   Transforming growth factor beta-1                                                 TGFB1       P01137
  125   Aldo-keto reductase family 1 member C3                                            AKR1C3      P42330
  126   Antileukoproteinase                                                               SLPI        P03973
  127   Apoptosis regulator Bcl-2                                                         Bcl2        P10417
  128   Aryl hydrocarbon receptor                                                         Ahr         P30561
  129   Cytochrome P450 1A2                                                               CYP1A2      P05177
  130   Gamma-aminobutyric-acid receptor alpha-2 subunit                                  GABRA2      P47869
  131   Glutathione S-transferase Mu 2                                                    GSTM2       P28161
  132   Hyaluronan synthase 2                                                             HAS2        Q92819
  133   Inhibitor of nuclear factor kappa-B kinase subunit beta                           IKBKB       O14920
  134   Mitogen-activated protein kinase 8                                                MAPK8       P45983
  135   Muscarinic acetylcholine receptor M1                                              CHRM1       P11229
  136   Nitric oxide synthase, endothelial                                                NOS3        P29474
  137   Nuclear receptor subfamily 1 group I member 2                                     NR1I2       O75469
  138   Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform   PIK3CG      P48736
  139   Prostaglandin G/H synthase 2                                                      PTGS2       P35354
  140   Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform           PPP3CA      Q08209
  141   Signal transducer and activator of transcription 1-alpha/beta                     STAT1       P42224
  142   Sodium-dependent noradrenaline transporter                                        SLC6A2      P23975
  143   Vascular cell adhesion protein 1                                                  VCAM1       P19320
  144   4-Aminobutyrate aminotransferase, mitochondrial                                   ABAT        P80404
  145   Alcohol dehydrogenase 1A                                                          ADH1A       P07327
  146   Alcohol dehydrogenase 1B                                                          ADH1B       P00325
  147   Alcohol dehydrogenase 1C                                                          ADH1C       P00326
  148   Caspase-3                                                                         CASP3       P42574
  149   CD44 antigen                                                                      CD44        P16070
  150   Intercellular adhesion molecule 1                                                 ICAM1       P05362
  151   Tumor necrosis factor                                                             TNF         P01375
  152   Mineralocorticoid receptor                                                        NR3C2       P08235
  153   Progesterone receptor                                                             PGR         P06401

[^1]: Academic Editor: Robert J. Lee
